IP Library Granted Patent US 12,293,839
Granted Patent B2
US 12,293,839 · App. 17/857,847 · Granted May 6, 2025

Candidate screening for a target therapy

Inventors: Lars Holdmann (Wettenberg, DE); Jannis Radeleff (Frankfurt, DE)
Assignee: St. Jude Medical, Cardiology Division, Inc.
G16H50/30G16H15/00G16H50/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,293,839
App. No.
17/857,847
Granted
May 6, 2025
Kind
B2
Abstract

Techniques are provided for candidate screening for a target therapy. A plurality of medical codes corresponding to patient billing data are identified. A candidate classification model for a target therapy is generated by selecting a set of medical codes from the plurality of medical codes and assigning a weight to each medical code selected. The candidate classification model is applied to patient billing data for a plurality of patients to generate a set of target therapy scores. The patient billing data includes associations between one or more patients of the plurality of patients and one or more medical codes of the plurality of medical codes. Each target therapy score corresponds to a patient of the plurality of patients, and is calculated based on weights for one or more medical codes associated with the patient.

Claims (29)

1. A method comprising:

performing, by one or more processors, the steps of:

identifying a plurality of medical codes corresponding to patient billing data, the plurality of medical codes including a first medical code corresponding to a risk for bleeding and a second medical code corresponding to existence of atrial fibrillation;

generating a candidate classification model for a target therapy by selecting a set of medical codes from the plurality of medical codes and assigning a weight to each medical code selected, the target therapy being a left atrial appendage (“LAA”) occlusion therapy;

receiving patient billing data for a plurality of patients, the patient billing data including associations between one or more patients of the plurality of patients and one or more medical codes of the plurality of medical codes;

applying the candidate classification model to the patient billing data to generate a set of target therapy scores, each target therapy score of the set of target therapy scores corresponding to a patient of the plurality of patients and calculated based on weights for one or more medical codes associated with the patient, wherein the set of target therapy scores includes (i) a first score indicating that the corresponding patient has previously received the LAA occlusion therapy, (ii) a second score indicating that the corresponding patient is at a high risk of stroke, and (iii) a third score indicating that the corresponding patient is not at a high risk of stroke; and

providing target therapy candidate data generated based on the set of target therapy scores;

based on the provided target therapy candidate data, identifying a selected patient from the plurality of patients, the target therapy score corresponding to the selected patient being the second score indicating that the selected patient is at the high risk of stroke; and

after identifying the selected patient, implanting a LAA occluder into the LAA of the selected patient to occlude the LAA of the selected patient.

2. The method of claim 1 , wherein the target therapy candidate data identifies one or more candidate patients having a target therapy score that meets a target therapy score threshold.

3. The method of claim 1 , wherein the target therapy candidate data includes an individual report for at least one patient of the plurality of patients.

4. The method of claim 1 , wherein the target therapy candidate data includes aggregate data for one or more target therapy classifications over one or more groupings of the plurality of patients.

5. The method of claim 1 , wherein generating the candidate classification model for the target therapy includes:

assigning one or more negative weights to one or more medical codes corresponding to one or more exclusion criteria for the target therapy; and

assigning one or more positive weights to one or more medical codes corresponding to one or more inclusion criteria for the target therapy.

6. The method of claim 1 , wherein generating the candidate classification model includes:

grouping two or more medical codes in the set of medical codes into a code group; and

assigning a single weight to the code group to indirectly assign weights to the two or more medical codes of the code group.

7. The method of claim 1 ,

wherein receiving the patient billing data includes receiving the patient billing data from a medical organization;

wherein providing the target therapy candidate data set comprises providing the set of target therapy scores to the medical organization;

wherein the patient billing data is received from the medical organization in a deidentified form; and

wherein the target therapy candidate data references individual patients in the plurality of patients by pseudonym.

8. The method of claim 1 , wherein generating the candidate classification model includes use of machine learning techniques to assign one or more weights of the candidate classification model based on a training data set comprising:

input data comprising associations between medical codes and a plurality of sample patients; and

output data comprising a sample target therapy score for each sample patient of the plurality of sample patients.

9. The method of claim 1 , further comprising:

receiving care provider review data corresponding to one or more target therapy scores of the set of target therapy scores; and

updating the candidate classification model by adjusting one or more weights assigned to the one or more medical codes of the set of medical codes based on the care provider review data.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2023
From: HOLDMANN, LARS; RADELEFF, JANNIS
To: ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.
Reel/Frame 064093/0125 →
Priority Claims (1)
DE 10 2022 116 219.2 · Jun 29, 2022 · national
Continuity (1)
Related Publication 20240006073A1 · Jan 4, 2024
References Cited (22)
US 20070203761A1 · Keen et al. · 2007 [cited by examiner]
US 20100169218A1 · Wang et al. · 2010 [cited by examiner]
US 20140249835A1 · Byrom · 2014 [cited by applicant]
US 20150039344A1 · Kinney et al. · 2015 [cited by examiner]
US 20150178874A1 · Harris et al. · 2015 [cited by examiner]
US 20160034986A1 · Ortiz · 2016 [cited by examiner]
US 20170235887A1 · Cox et al. · 2017 [cited by examiner]
US 20170344709A1 · Dey et al. · 2017 [cited by examiner]
US 20180374844A1 · Nishida et al. · 2018 [cited by examiner]
US 20190125362A1 · Tischler · 2019 [cited by examiner]
US 20200027531A1 · White · 2020 [cited by applicant]
US 20200035360A1 · Vest · 2020 [cited by applicant]
US 20200226321A1 · Burns et al. · 2020 [cited by examiner]
US 20210085330A1 · Sauer · 2021 [cited by examiner]
US 20220044826A1 · Schaeffer et al. · 2022 [cited by examiner]
US 20220084633A1 · Das et al. · 2022 [cited by examiner]
US 20220319643A1 · Skees et al. · 2022 [cited by examiner]
US 20230071973A1 · Freedholm et al. · 2023 [cited by examiner]
WO 2015187154 · 2015 [cited by applicant]
WO 2019168956 · 2019 [cited by applicant]
Consulting Contract, dated May 30, 2022. [cited by applicant]
Holmes, David R., et al. “Left atrial appendage occlusion: opportunities and challenges.” Journal of the American College of Cardiology 63.4 (2014): 291-298. [cited by applicant]